Dr. Jürgen Schumacher is a Co-Founder and serves as Chairman and Advisor at Algiax Pharmaceuticals. He serves as Advisor at Numaferm. Jürgen Schumacher is one of Germany's leading biotech entrepreneurs with more than 20 years' experience in the industry. He sits on the boards of many companies but mostly those involved in the biotech industry. Jürgen was co-founder of Qiagen and acted as spokesperson for the board. He has founded many companies in Germany including NewLab BioQuality which was recently sold to a large US company. Moreover, he is a member of numerous biotech associations and is a consultant for the biotechnology activities in North-Rhine Westphalia. He served as Chief Executive Officer at Spinal Cord Therapeutics.